>>> Bayer AG Reaffirms FY14 Rev +5% to €41-42B after -2% FX impact, adj EBITDA g Bayer AG Reaffirms FY14 Rev +5% to €41-42B after -2% FX impact, adj EBITDA growth in low- to mid-single-digit percentage after 5% FX impact, core EPS up mid-single-digits after -6% FX effect - analyst slides slides